Psychiatry 27 , 29402949 (2022)
Data analysis Pharmacological data were analysed using a 3-parameter logistic fit in Prism (v8.2, GraphPad)
* For this use, Wegovy has received Read next: Wegovy for Weight Loss Zepbound is not approved for use in children
With orforglipron offering additional advantages such as the elimination of strict pre-dosing requirements, potential lower cost, and easier storage, it will be important to see whether these features lead to even greater adherence, says Priya Jaisinghani, a diabetes and obesity medicine specialist at NYU Langone
Major population health real-world studies such as SCoMIS, which examines the use of Wegovy in the Scottish population will read-out by 2029, and SURMOUNT-REAL will provide definitive insights into whether use of Obesity Medicines brings healthcare system benefits in the form of, for example, reduced cardiovascular events, diabetes or disability, and may also provide data on wider socio-economic benefits, such as reduced unemployment
